Markéta Chlubnová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Markéta Chlubnová has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Asbjørn Christophersen
KG Jebsen Coeliac Disease Research Centre University of Oslo Oslo 0372 Norway
1 shared publication - Bjørn Tore Gjertsen
Haukeland University Hospital Bergen Norway
1 shared publication - Geir Kjetil Sandve
Department of Informatics, University of Oslo, Norway
1 shared publication - Jorrit Martijn Enserink
Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway
1 shared publication - Joseph Robertson
Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
1 shared publication - Jørgen Jahnsen
Department of Gastroenterology, Akershus University Hospital
1 shared publication
Latest Publications
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eade5800
Identification of gluten T cell epitopes driving celiac disease
CD4 + T cells specific for cereal gluten proteins are key players in celiac disease (CeD) pathogenesis. While several CeD-relevant gluten T cell epitopes have been identified, epitopes recognized by a substantial proportion of gluten-reactive T cells remain unknown. The identification of such CeD-driving gluten epitopes is important for the food industry and in clinical settings. Here, we have combined the knowledge of a distinct phenotype of gluten-reactive T cells and key features of known gluten epitopes for the discovery of unknown epitopes. We tested 42 wheat gluten–reactive T cell clones, isolated on the basis of their distinct phenotype and with no reactivity to known epitopes, against a panel of synthetic peptides bioinformatically identified from a wheat gluten protein database. We were able to assign reactivity to 10 T cell clones and identified a 9-nucleotide oligomer core region of five previously uncharacterized gliadin/glutenin epitopes. This work represents an advance in the effort to identify CeD-driving gluten epitopes.
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eade5800
Identification of gluten T cell epitopes driving celiac disease
CD4 + T cells specific for cereal gluten proteins are key players in celiac disease (CeD) pathogenesis. While several CeD-relevant gluten T cell epitopes have been identified, epitopes recognized by a substantial proportion of gluten-reactive T cells remain unknown. The identification of such CeD-driving gluten epitopes is important for the food industry and in clinical settings. Here, we have combined the knowledge of a distinct phenotype of gluten-reactive T cells and key features of known gluten epitopes for the discovery of unknown epitopes. We tested 42 wheat gluten–reactive T cell clones, isolated on the basis of their distinct phenotype and with no reactivity to known epitopes, against a panel of synthetic peptides bioinformatically identified from a wheat gluten protein database. We were able to assign reactivity to 10 T cell clones and identified a 9-nucleotide oligomer core region of five previously uncharacterized gliadin/glutenin epitopes. This work represents an advance in the effort to identify CeD-driving gluten epitopes.
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100179
A cell competition–based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100179
Open AccessA cell competition–based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation